Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00625924 · ClinicalTrials.gov registry record
Sensory Morbidity Following Breast Surgery
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 290
- Enrollment target
NCT00625924: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT00625924 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 290 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00625924 has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 290 participants
- Enrollment target
Study Summary
The goal of the study is measure breast sensations after breast surgery. The results of this study will help surgeons better understand breast sensations and may improve the way surgery is done.
Interventions
- BEHAVIORAL questionnaires
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 290 participants |
| Start Date | 2008-02 |
| Est. Completion | 2014-01 |
What the finished NCT00625924 record still lists
NCT00625924 is an observational study that tracks outcomes without assigning an intervention. The registered 290 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which questionnaires is the first listed.
NCT00625924 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00625924 about?
NCT00625924 is a clinical study titled "Sensory Morbidity Following Breast Surgery". The goal of the study is measure breast sensations after breast surgery. The results of this study will help surgeons better understand breast sensations and may improve the way surgery is done.
What is the current status of trial NCT00625924?
This trial is currently completed. The enrollment target is 290 participants. The study started on 2008-02. Estimated completion is 2014-01.
What interventions are being tested in trial NCT00625924?
The interventions under investigation include: questionnaires (BEHAVIORAL).
Who is sponsoring clinical trial NCT00625924?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00775476 · 290 participants · Phase 2
Treatment of Systemic Lupus Erythematosus (SLE) With N-acetylcysteine
- NCT01874197 · 290 participants · NA
Branched Thoracic Endovascular Grafts for the Treatment of Thoraco-abdominal Aortic
- NCT04331353 · 290 participants · NA
The Allergen Reduction and Child Health Study (ARCHS)
- NCT04649008 · 290 participants · Early Phase 1
Localizing Epileptic Networks Using MRI and iEEG
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia